Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common hereditary subcortical vascular dementia. CADASIL is caused by mutations in NOTCH3 gene, which encodes a large transmembrane receptor NOTCH3. The key pathological finding is the accumulation of granular osmiophilic material (GOM), which contains extracellular domains of NOTCH3, on degenerating vascular smooth muscle cells (VSMCs). CADASIL is usually suspected on the basis of patient's clinical picture, relatively characteristic findings in brain MRI and information on family history. Definite diagnosis can be established by molecular genetic detection of a pathogenic mutation in NOTCH3 gene. The gene analysis may, however, be laborious, due to the high number of different pathogenic mutations (over 200 at present) and besides, comprehensive genetic analyses are available only in few genetic laboratories. However, CADASIL is a unique dementing disorder, because it is also possible to diagnose it at a high level of certainty by a skin biopsy using electron microscopic (EM) or immunohistochemical (IHC) analysis of dermal arteries.
CADASIL
2.1 Epidemiology CADASIL, the most common hereditary vascular dementia, is characterized by migraineous headache with aura, recurrent ischemic attacks, cognitive decline and psychiatric symptoms as the four main features. Migraneous headache with aura occurs in about one third of patients and it may begin already before the age of 10 years (Kalimo et al., 2008) . The age at first ever stroke varies widely, usually from 25 to 65 years [yet, the youngest patient who has suffered from a stroke was 11 years-of-age (Granild-Jensen et al., 2009) ].
Etiology
CADASIL is caused by mutations in NOTCH3 gene encoding a transmembrane receptor NOTCH3 (Joutel et al., 1996) . Virtually all pathogenic mutations lead to an odd number of cysteine residues in one of the 34 epidermal growth factor (EGF) like repeats in the extracellular domain of NOTCH3 (N3ECD). The mutations result in degeneration of vascular smooth muscle cells (VSMC), in which NOTCH3 is predominantly expressed in adult humans . The main pathological findings are accumulation of N3ECD on degenerating VSMCs as well as fibrosis and thickening of arterial walls, stenosis of arterioles and lacunar infarcts (Miao et al., 2004 , Ruchoux et al., 1995 . In electron microscopy (EM) the pathognomonic feature of CADASIL is accumulation of granular osmiophilic material (GOM) in indentations of the VSMCs or in the extracellular space in close vicinity to VSMCs (Baudrimont et al., 1993 , Ruchoux et al., 1995 . The exact composition of GOM has not been elaborated, but an immunogold EM study suggested N3ECD to be a component of GOM (Ishiko et al., 2006) . 
Vascular pathology 2.3.1 Brain arteries
Pathological changes are present in all small to medium-sized arteries of the body and in some veins and capillaries. In small arterioles in cerebral white matter (WM) histological stainings reveal markedly thickened walls with accumulation of N3ECD in the degenerating tunica media. This material is basophilic in H&E ( Figure 1A and B) and red in PAS stainings. Decreased immunopositivity for -smooth muscle actin (-SMA) reveals degeneration of the VSMCs ( Figure 1C ). The accumulation of N3ECD can be verified by immunohistochemical staining ( Figure 1D ). Accumulation of extracellular matrix proteins, including various types of collagens and fibronectin and vimentin outside the degenerating VSMCs causes the thickening of the vessel walls ( Figures 1A-D) . On the basis of the stainings above CADASIL can be distinguished from the two other arteriopathies with thickened walls: In arteriolosclerosis (Binswanger disease) and cerebral amyloid angiopathy the walls are homogeneously stained, either like collagen or like amyloid. The brain arteries are usually not studied until post mortem, when the degeneration of VSMCs and the accumulation of GOM are already obvious at the LM level. Thus, EM examination is not needed and is usually not performed.
Dermal arterioles -appearance of GOM
Skin biopsies are most often performed and the specimens examined at earlier stages of CADASIL, often when the diagnosis is only suspected. In histological sections the skin usually looks relatively normal: the possible thickening of the walls of small arteries within the dermal connective tissue is difficult to discern. Thus, either EM or IHC examination is needed. EM analysis of an arterial wall reveals enlarged subendothelial space and the degenerating VSMCs which appear irregularly shaped as they have lost their intercellular connections (Figure 2 ; Maurage, 1997, Kalimo et al., 2008) . As a striking and pathognomonic feature of CADASIL, GOM accumulates on VSMCs (Baudrimont et al., 1993 , Ruchoux et al., 1995 . Already before the gene defect was found, GOM was detected in skin biopsies from CADASIL patients (Ruchoux et al., 1994) . So far GOM has not been described in any other disease entity: GOM is negative in both histological (e.g. Congo red and thioflavin) and immunohistochemical stainings for different amyloid angiopathies (Ragno et al., 1995, Ruchoux and Maurage, 1997) . GOM accumulates in the arterial wall, in the tunica media and is usually detected in the close vicinity to VSMCs, often in small indentations of VSMC plasma membrane within the basal lamina (Figures 2 and 3A) , which is usually irregularly thickened, or GOM lies free in the extracellular space (Figures 2 and 6C .). The indentations are often associated with caveolar structures ( Figure 3A ), but as caveolae are common structures of VSMCs, their pathogenetic significance is unclear. The size of GOM deposits is variable, ranging from 0.2 µm to 0.8 µm, and they are composed of 10-15 nm granules (Ruchoux and Maurage, 1997 ). GOM appears in EM as evenly electron dense or, as often, denser on the side which is towards the VSMC membrane ( Figure 3A ). The exact composition of GOM has not been fully clarified, but N3ECD is a component of GOM as demonstrated by immunoelectron microscopy (Ishiko et al., 2006) . Moreover, with confocal microscopy, N3ECD immunoreactivity can be seen as dot-like accumulations on the arterial wall, in concordance with the appearance of GOM deposits in the EM ( Figure 3B ). The degeneration of VSMCs and the accumulation of GOM begin early and the morphological changes in arteries and the accumulation of GOM are already detectable before the age of 20 (Tikka et al., 2009) ( Figure 3C ). (Kalimo et al., 2008) Figure 4B ; Chabriat et al., 1998) . Laboratory examinations are usually non-rewarding or non-specific, i.e. the examinations may reveal risk factors of other cerebrovascular diseases. Figure 4A is reproduced with permission of Future Neurology (Kalimo et al., 2008) 
Genetic analysis
The definite verification of the diagnosis can be done by identifying a pathogenic mutation in the NOTCH3 gene. However, over 200 different mutations in 20 different exons have been reported to cause CADASIL (Tikka et al., 2009 , Junna et al. 2011 . Comprehensive analysis of all these exons is time consuming and costly. Thus, most diagnostic laboratories screen only the exons that according to the previous reports harbour majority of the mutations (Dotti et al., 2005 , Escary et al., 2000 , Joutel et al., 1997 , Kalimo et al., 2002 , Opherk et al., 2004 . Of the all reported pathogenic NOTCH3 mutations 62% locate in exons 3, 4, 5 and 8. Furthermore, to obtain 80 % coverage, additional investigation of exons 2, 6, 11 and 18 is required (Tikka et al., 2009) . Mutation screening covering the whole region coding for EGF repeats (exons 2-24) is not realistic for all patients and for most laboratories.
Skin biopsy
Given the challenging factors complicating comprehensive genetic analyses it is fortunate that CADASIL is also possible to diagnose by skin biopsy using EM or IHC examination.
EM analysis
Although GOM has not been detected in any other disease and the specificity is considered to be 100% (Ebke et al., 1997 , Mayer et al., 1999 , Markus et al., 2002 , Razvi et al., 2003 ) the reports on the sensitivity of detecting GOM in skin biopsy of patients with genetically verified CADASIL have been contradictory. Two earlier studies on a smaller number of patients suggested 100% sensitivity (Ebke et al., 1997 , Mayer et al., 1999 in which Ebke et al. analysed one family with 8 patients (mutation not specified) and 5 controls suffering from sporadic leukoencephalopathies and Mayer et al. examined 14 patients (mutation not specified) from three unrelated families. Two more recent papers have reported a low sensitivity: Markus et al. (2002) reported GOM detected only in 8 patients out of 18, thus giving a sensitivity of only 44.4%. Razvi et al. (2003) suspected that the sensitivity might be even lower, although they did not give an exact number. In the latest EM study in a cohort of 131 CADASIL patients and 26 control subjects GOM was detected in all skin biopsies from mutation positive patients and in none of the control biopsies (Tikka et al., 2009 ). This study was a retrospective investigation of a combined patient material from Finland, Sweden and France comprising 131 patients, from whom both the genetic analysis and EM examination of skin biopsy were available. Skin biopsies from 26 mutation negative members in genetically proven CADASIL families served as controls. This study showed that EM demonstration of GOM in skin biopsy is a highly reliable and practical method to screen for or even specifically diagnose CADASIL. Furthermore, the intensive search for mutations based on confidence in the diagnostic specificity of GOM resulted in discovery of four novel, previously unreported mutations, among them the first duplication of three codons (Tikka et al., 2009) . Thus the detection of GOM in skin biopsies is a highly reliable diagnostic method: in this large cohort the congruence between NOTCH3 mutations and presence of GOM was 100% (Tikka et al., 2009) .
Technical requirements
When using EM analysis of skin biopsy as a diagnostic method in suspected CADASIL cases, special attention should be paid to the quality and analysis of the skin biopsy. The GOM is best detectable generally from medium sized or small arterioles (usually outer diameter 20-40 µm) in deep dermis or upper subcutis, but in a few cases GOM has been detected also in veins (Tikka et al. 2009 , Fig. 6B ) and capillaries (Lewandowska et al., 2010) . The detection of fragmented lamina elastica interna as dark blue dots in toluidine blue semithin sections ( Figure 5 ) is a good marker of representative arterioles. Technical factors in the processing of the samples may also influence the result. Since GOM is osmiophilic, the osmium tetroxide treatment should be adjusted such that GOM becomes sufficiently well contrasted. Furthermore, if GOM is not detected in the first vessel investigated, other vessels or even repeat biopsies should be examined. Besides, examination should be targeted rather to an artery/arteriole (with multiple layers of VSMCs and inner elastic lamina) than a vein or a capillary, since veins and capillaries are not always GOM positive (Figure 6 ). Of course, a prerequisite is that the investigator recognizes GOM correctly and distinguishes it from fallacious deposits like small clumps of cell debris or fragmented ECM proteins (Figure 7) . 
Immunohistochemistry
IHC showing accumulation of N3ECD in the tunica media of small arteries is another microscopic method to diagnose CADASIL, the availability of IHC being, of course, better than that of EM. Joutel et al. (2001) introduced IHC as a diagnostic tool in CADASIL. In that study they showed in a cohort of 39 patients (23 patients, 16 controls) that sensitivity of N3ECD staining was 96% and specificity 100%. Another study with a cohort of 41 NOTCH3 mutation carriers, 21 controls and 10 hereditary cerebral hemorrhage with amyloidosis-Dutch (HCHWA-D) patients reported sensitivity of 85.4-90.2% and specificity of 95.2-100% (Lesnik Oberstein et al., 2003) . Both studies reported false negatives which were associated with mutations in exon 11 (Joutel et al., 2001 , Lesnik Oberstein et al., 2003 . In addition, nonspecific staining is an inherent caveat of IHC producing false positives (Lesnik Oberstein et al., 2003) . In the latest immunohistochemical study on 93 skin biopsies from subjects with suspected CADASIL the sensitivity and specificity of the skin biopsies were 97.7% and 56.5%, respectively though in familial cases the values improved to 100% and 81.5% (Ampuero et al., 2009) . Specificity was limited in that study by incomplete sequencing of NOTCH3 (sequenced exons: 2-6, 8, 11, 14, 18, 19, 22 and 23) . Although IHC is relatively sensitive and highly specific, given the possibility of false negatives and positives, it should not be used as definitive tool for diagnostics but to help other methods of choice. (Tikka et al., 2009 ).
Diagnostic workflow
What would be the most efficient strategy to confirm the clinical suspicion of CADASIL? Strategy strongly depends on the family history of patient and the mutational background in the population to which the suspected patient belongs. In families with a known mutation, the method of choice is, of course, to analyse directly that mutation. If the patient´s population harbours known founder or major mutations, the diagnostic workup is best to begin by first screening for those mutations. In populations with no known founder or other prevailing mutations, screening of the known mutational hot spot region of the NOTCH3 gene should be the first genetic method to search for CADASIL. To obtain 80 % coverage of the reported CADASIL mutations investigation of exons 2-4, 5, 6, 8, 11 and 18 is required (Tikka et al., 2009 Supplement table 1). After these analyses EM or IHC analysis of a skin biopsy for detection of GOM or accumulation of N3ECD is highly recommended. Similar approach has been suggested by Peters et al. (2005) . Mutation screening covering the whole region coding for EGF repeats (exons 2-24) is not realistic for all suspected patients and for most diagnostic laboratories. N3ECD the immunostaining has been found reliable method in cases with at least a fair amount of accumulated N3ECD (Joutel et al., 2001 ). However, if only a small amount of the N3ECD has accumulated, e.g. at the early stage of the disease, ultrastructural resolution and characteristic appearance of GOM most likely make the EM analysis more reliable. We have detected GOM even in patients below the age of 20 years ( Figure 3C ). Besides, nonspecific staining producing false positives is an inherent caveat of immunohistochemistry (Lesnik Oberstein et al., 2003) , which may cause problems also in CADASIL cases with only small amounts of N3ECD giving rise to false negatives. Moreover, EM examination provides also information about other pathological changes in the arterial wall, such as those due to hypertension, ageing and possibly even other hereditary arteriopathies , Ruchoux et al., 2000 . The Swedish family with multi-infarct dementia was previously thought to be the first published pedigree with CADASIL (Sourander and Walinder, 1977) . The absence of GOM in the arteries was an important piece of evidence in addition to the negative genetic analyses in the demonstration that this family suffers from another hereditary vascular dementia (Low et al., 2007) . On the other hand, another cerebral small vessels disease caused by a novel type of pathogenic mutation (p.Leu1515Pro) in the exon 25 of NOTCH3 outside the EGF like repeat rich domain, results in constitutively active NOTCH3 receptor (Fouillade et al., 2008) . This leads to increased signaling in a ligandindependent fashion, possibly due to destabilization of the NOTCH3 heterodimer. Remarkably, in this single patient reported there is no deposition of N3ECD and GOM on VSMCs.
Conclusion
The strategy of the CADASIL workup should be based on logical evaluation of clinical findings, family history as well as on both genetic and morphological methods available. Demonstration of a known pathogenic mutation provides indisputable evidence for the disease and gives a practical tool to clarify genetic counselling in the family. In those cases, in which the mutation is not easy to identify or genetic analysis is not available, skin biopsy is easy to perform. IHC showing accumulation of N3ECD can also be used as a supportive method in diagnostic process although it should not be used as only method. Detection of GOM by EM should be preferable method when analysing skin biopsies given its high specificity and sensitivity. Neither is it time consuming nor excessively expensive. Importantly, it is invaluable in guiding, how far one should proceed with the genetic analyses.
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